losartan has been researched along with Sick Sinus Node Syndrome in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takii, E | 1 |
| Inage, T | 1 |
| Yoshida, T | 1 |
| Ohe, M | 1 |
| Gondo, T | 1 |
| Haraguchi, G | 1 |
| Ito, S | 1 |
| Kumanomido, J | 1 |
| Imaizumi, T | 1 |
| Fukuomoto, Y | 1 |
1 trial available for losartan and Sick Sinus Node Syndrome
| Article | Year |
|---|---|
Beneficial effects of losartan for prevention of paroxysmal atrial fibrillation in patients with sick sinus syndrome: analysis with memory function of pacemaker.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Anti-Arrhythmia Agents; Atrial Fibrillation; Biologic | 2016 |